Literature DB >> 2788937

Relapse of Pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis.

R M Bradburne1, D B Ettensohn, S M Opal, F D McCool.   

Abstract

Pneumocystis carinii pneumonia was diagnosed by bronchoalveolar lavage of the upper lobes in a patient with the acquired immunodeficiency syndrome (AIDS) receiving aerosol pentamidine prophylaxis. Serendipitous availability of a normal premorbid lung gallium scan indicated that pneumocystosis had developed during aerosol pentamidine prophylaxis; at the time of presentation a repeat gallium scan indicated disease limited to the upper lobes. The relation of this unusual form of isolated upper lobe Pneumocystis carinii pneumonia to aerosol pentamidine prophylaxis warrants further investigation.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2788937      PMCID： PMC461971          DOI： 10.1136/thx.44.7.591

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  4 in total

1.  Bilateral upper lobe Pneumocystis carinii pneumonia in a patient receiving inhaled pentamidine prophylaxis.

Authors:  A G Abd; D M Nierman; J S Ilowite; R N Pierson; A L Bell
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

2.  Pneumocystis pneumonia increases the clearance rate of inhaled 99mTc DTPA from lung to blood.

Authors:  D K Jones; T W Higenbottam
Journal:  Chest       Date:  1985-10       Impact factor: 9.410

3.  Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS.

Authors:  L J DeLorenzo; C T Huang; G P Maguire; D J Stone
Journal:  Chest       Date:  1987-03       Impact factor: 9.410

4.  Correlation between gallium lung scans and fiberoptic bronchoscopy in patients with suspected Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome.

Authors:  D L Coleman; R S Hattner; J M Luce; P M Dodek; J A Golden; J F Murray
Journal:  Am Rev Respir Dis       Date:  1984-12
  4 in total
  8 in total

Review 1.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

Review 2.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Relapse of pneumocystis pneumonia in the upper lobes during aerosol pentamidine prophylaxis.

Authors:  M J O'Doherty; S H Thomas; N T Bateman
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

Review 4.  Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia.

Authors:  J P Monk; P Benfield
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

5.  Antibiotic penetration into lung tissues.

Authors:  D Honeybourne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

Review 6.  Early chronic obstructive pulmonary disease: definition, assessment, and prevention.

Authors:  Stephen I Rennard; M Bradley Drummond
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

7.  Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment.

Authors:  K J Holroyd; R Buhl; Z Borok; J H Roum; A D Bokser; G J Grimes; D Czerski; A M Cantin; R G Crystal
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

8.  Upper lobe relapse of Pneumocystis carinii pneumonia during aerosolized pentamidine prophylaxis.

Authors:  S Köppen; T Grünewald; G Jautzke; B Ruf
Journal:  Klin Wochenschr       Date:  1991-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.